Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Steps in Outbreak Investigation

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:

Principles of Disease Surveillance

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

FDA Approved Drugs: Changes to Approved Drugs

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Preventing Disease Emergence Following Eradication: Application to Mpox.

bioRxiv : the preprint server for biology·2026

Same author

AI and the Future of Medical Countermeasures to Protect Against Biological Threats.

Open forum infectious diseases·2026

Same author

Unpacking sources of transmission in HIV prevention trials with deep-sequence pathogen data.

Nature communications·2026

Same author

Use of the test-negative design to estimate the protective effect of a scalar immune measure: a simulation analysis.

American journal of epidemiology·2026

Same author

Reply to Lowen et al., "The value of virological research in wildlife".

mBio·2026

Same author

Geographic spillover of antimicrobial resistance from mass distribution of azithromycin.

Nature communications·2026

Same journal

Comparative analysis of gut viromes in four penguin species reveals diverse novel viruses and host-associated differences.

mSphere·2026

Same journal

Systems analysis reveals alternate metabolic states adopted by <i>Mycobacterium tuberculosis</i> across species.

mSphere·2026

Same journal

HIV-1 and <i>Chlamydia trachomatis</i> limit their respective growth but promote their survival in co-infected human macrophages.

mSphere·2026

Same journal

Salinity-driven microbial adaptation of hydrocarbon-degrading communities in coastal sediments.

mSphere·2026

Same journal

Tools for genetic manipulation of the endemic fungal pathogen <i>Emergomyces africanus</i> and application of a fluorescent reporter strain in infection models.

mSphere·2026

Same journal

Cysteine-S-nitrosylation inhibits ROP5-mediated immune evasion in <i>Toxoplasma gondii</i>.

mSphere·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 30, 2025

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology

Published on: October 3, 2016

Proposed Changes to U.S. Policy on Potential Pandemic Pathogen Oversight and Implementation.

Thomas V Inglesby¹, Marc Lipsitch²

¹Center for Health Security, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA tinglesby@jhu.edu.

|January 24, 2020

Summary

This summary is machine-generated.

This study proposes policy changes for potential pandemic pathogen (PPP) oversight, advocating for transparency, responsible publication, and international collaboration in enhanced PPP research to improve biosafety and biosecurity globally.

Keywords:

biosafety biosecurity policy potential pandemic pathogen research regulation

More Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes

Published on: July 4, 2007

Related Experiment Videos

Last Updated: Dec 30, 2025

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology

Published on: October 3, 2016

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes

Published on: July 4, 2007

Area of Science:

Public Health Policy
Biosafety and Biosecurity
Infectious Disease Research

Background:

Current U.S. government policies for potential pandemic pathogen (PPP) oversight require updates.
Enhanced PPP research necessitates robust biosafety and biosecurity measures.
A fragmented international approach to enhanced PPP research poses risks.

Purpose of the Study:

To propose revisions to U.S. government policy on PPP oversight.
To advocate for enhanced transparency in the review and publication of PPP research.
To promote a unified international strategy for managing enhanced PPP research.

Main Methods:

Policy analysis and proposal development.
Emphasis on transparency in review processes and research content.
Advocacy for best practices in biosafety and biosecurity.

Main Results:

Recommendations for increased transparency in PPP review and publication.
Proposal for high-level approval of enhanced PPP experiments.
Call for international harmonization of PPP research standards.

Conclusions:

Implementing transparent policies and best practices is crucial for responsible enhanced PPP research.
International cooperation is essential for global biosafety and biosecurity in PPP research.
Adoption of these recommendations by funders and journals will strengthen oversight.